Cancer Clinical Trial
Patient Navigation in the Adolescent and Young Adult (AYA) Cancer Population
|Source||H. Lee Moffitt Cancer Center and Research Institute|
|Start date||May 31, 2017|
|Completion date||December 2019|
The purpose of this study is to develop and test a model of patient navigation that investigators hope will address the unique needs of adolescent and young adult (AYA) cancer patients and their families by minimizing barriers in their care and potentially improving the outcomes of their treatment while reducing distress and enhancing quality of life. Investigators plan to achieve this by increasing access to, and use of, the resources available at Moffitt Cancer Center for AYA patients and their families.
Up to 80 participants may be recruited to this study at Moffitt Cancer Center to obtain a
final sample size of 60 completed participants.
Participants will be identified in consultation with the patient's primary oncologist and program social worker. A research assistant (RA) will verify eligibility and consent eligible patients.
After completing a baseline questionnaire, participants will be randomly placed into one of two groups. Both groups will receive their normal care, but one group will also meet with a patient navigator. Participants in both groups will be asked to complete a follow-up questionnaire approximately 8 to 10 weeks from when they complete the baseline questionnaire. The follow-up questionnaire will take about 15 to 20 minutes to complete.
Participation in the study will last about 10 weeks.
|Recruiting||NCT01285037 - A Study of LY2801653 in Advanced Cancer||Phase 1|
|Active, not recruiting||NCT00680992 - Study of Denosumab in Subjects With Giant Cell Tumor of Bone||Phase 2|
|Completed||NCT00340522 - Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development||N/A|
|Terminated||NCT01441115 - ECI301 and Radiation for Advanced or Metastatic Cancer||Phase 1|
|Completed||NCT01077414 - Phenomenological Study of Psycho-Socio-Spiritual Healing in the Context of Chronic or Life-Threatening Illness||N/A|
|Active, not recruiting||NCT00587886 - Estrogen, Diet, Genetics and Endometrial Cancer||N/A|
|Enrolling by invitation||NCT02565004 - Clinical and Laboratory Analysis of Familial Cancer||N/A|
|Recruiting||NCT02839889 - Tolerability, Safety, and Feasibility of Naloxegol in Patients With Cancer and OIC (Opioid Induced Constipation)||Phase 4|
|Recruiting||NCT02891993 - Pilot Study of a Symptom Monitoring Intervention for Hospitalized Patients With Cancer||N/A|
|Recruiting||NCT02869802 - Prospectively Defining Metastatic Pancreatic Ductal Adenocarcinoma Subtypes by Comprehensive Genomic Analysis||N/A|
|Recruiting||NCT02921919 - Open-Label Extension and Safety Study of Talazoparib||Phase 2|
|Not yet recruiting||NCT02883699 - Individually Tailored Training Prescriptions in Cancer Patients: The TOP Study||N/A|
|Recruiting||NCT02758639 - Wonders & Worries: A Clinical Trial of a Psychosocial Intervention for Children Who Have a Parent With Cancer||N/A|
|Recruiting||NCT02550925 - Acceptance and Commitment Therapy (ACT) for Anxious Cancer Survivors||N/A|
|Recruiting||NCT02552953 - A Pharmacologic Study of CYC065, a Cyclin Dependent Kinase Inhibitor, in Patients With Advanced Cancers||Phase 1|
|Recruiting||NCT02662621 - Pilot Study With the Aim to Quantify a Stress Protein in the Blood and in the Urine for the Monitoring and Early Diagnosis of Malignant Solid Tumors||N/A|
|Recruiting||NCT02866851 - Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy||N/A|
|Recruiting||NCT02528357 - GSK3174998 Alone or With Pembrolizumab in Subjects With Advanced Solid Tumors (ENGAGE-1)||Phase 1|
|Recruiting||NCT02483247 - A Study of BBI503 in Combination With Selected Anti-Cancer Therapeutics in Adult Patients With Advanced Cancer||Phase 1/Phase 2|
|Recruiting||NCT02502396 - Rivaroxaban Utilization for Treatment and Prevention of Thromboembolism in Cancer Patients: Experience at a Comprehensive Cancer Center||N/A|